MIIP and non-small cell lung carcinoma: Research has indicated that MIIP has the capability to expedite the degradation of EGFR while concurrently suppressing the downstream Ras/MEK/ERK signaling cascade, consequently curbing the proliferation and metastasis of non-small cell lung cancer (Wen et al. 2016).